S-23

Description

S-23 is a non-steroidal selective androgen receptor modulator (SARM) developed for research into androgen receptor pharmacology, skeletal muscle biology, and endocrine regulation. It is one of several experimental SARMs designed to selectively activate androgen receptors in target tissues while providing a platform for studying tissue-selective anabolic signaling.

S-23 has been investigated primarily for its high binding affinity to the androgen receptor and its effects on muscle and bone physiology. Upon binding to the androgen receptor, the receptor-ligand complex regulates the transcription of genes involved in protein metabolism, muscle maintenance, cellular differentiation, and bone remodeling. Although S-23 demonstrates potent biological activity in laboratory studies, its complete receptor pharmacology and tissue-selective mechanisms remain under investigation.

Research has explored its influence on lean tissue preservation, skeletal muscle physiology, bone biology, and reproductive endocrine function. Human clinical studies evaluating its pharmacokinetics, efficacy, and long-term safety have not been published in sufficient detail, and its biological effects in humans remain incompletely characterized.

Product Specifications

• Compound / Peptide name: S-23
• Classification: Selective Androgen Receptor Modulator (SARM); non-steroidal androgen receptor agonist
• Sequence (if applicable): Not applicable
• Molecular Formula: Not available
• Form: Tablet
• Strength: 10 mg per tablet
• Purity: 99%
• Appearance: Tablet form; physical characteristics depend on formulation
• Storage: Store according to supplier specifications in a cool, dry environment
• Solubility: Research-dependent
• Regulatory Status: Investigational research compound; not approved for human therapeutic use

What Is It Used For and Its Purpose 

S-23 is primarily used as a research compound to investigate selective androgen receptor activation and its effects on skeletal muscle, bone tissue, and endocrine physiology. Experimental studies have utilized S-23 to better understand anabolic signaling pathways and tissue-selective androgen receptor modulation.

Researchers have explored S-23 in laboratory models examining protein metabolism, lean tissue regulation, bone remodeling, and hormonal feedback mechanisms. In addition to musculoskeletal research, the compound has been studied for its effects on reproductive endocrinology because of its influence on the hypothalamic-pituitary-gonadal axis observed in preclinical models.

S-23 serves as a valuable pharmacological tool for investigating how selective androgen receptor agonists regulate gene expression and cellular physiology without reproducing all biological actions associated with endogenous androgens or anabolic steroids.

Research Application

• Endocrinology
• Androgen receptor signaling
• Skeletal muscle biology
• Bone metabolism
• Molecular pharmacology
• Protein metabolism
• Body composition research
• Reproductive endocrinology

Potential Scientific Benefits 

Experimental research has demonstrated that S-23 possesses potent androgen receptor agonist activity in laboratory models. Preclinical investigations have examined its ability to regulate anabolic signaling pathways associated with skeletal muscle maintenance and bone physiology. Studies have reported increases in lean tissue parameters and preservation of muscle mass relative to experimental controls under certain study conditions. These observations are believed to result from androgen receptor-mediated regulation of genes involved in protein synthesis and muscle remodeling.

S-23 has also been investigated for its effects on bone biology, where androgen receptor activation may influence bone remodeling and mineral homeostasis. Additionally, preclinical studies have demonstrated significant suppression of endogenous reproductive hormones, making endocrine regulation an important area of ongoing research involving this compound.

Observed biological activities in research

• Selective activation of androgen receptors
• Investigation of anabolic signaling pathways
• Regulation of skeletal muscle protein metabolism
• Effects on bone remodeling in preclinical models
• Modulation of reproductive endocrine signaling
• Investigation of tissue-selective androgen receptor pharmacology

Molecular mechanisms reported

• Androgen receptor agonism
• Regulation of androgen-responsive gene transcription
• Influence on protein synthesis-related signaling pathways
• Modulation of endocrine feedback mechanisms

Physiological pathways involved

• Androgen receptor signaling
• Skeletal muscle protein metabolism
• Bone remodeling pathways
• Hypothalamic-pituitary-gonadal axis regulation

Experimental outcomes in models

• Increased lean tissue parameters in animal studies
• Investigation of muscle preservation mechanisms
• Changes in reproductive hormone regulation
• Evaluation of bone-related biological responses

Current evidence remains limited, and further well-controlled clinical studies are required to establish long-term efficacy and safety in humans.

Research Data Sheet

• Compound / Peptide name: S-23
• Sequence (if applicable): Not applicable
• Classification: Selective Androgen Receptor Modulator (SARM)
• Molecular Formula: Not available
• Molecular Weight: Not available
• Form: Tablet
• Appearance: Tablet form
• Purity: 99%
• Solubility: Research-dependent
• Storage: Store according to supplier specifications
• Research Categories: Endocrinology, androgen receptor signaling, skeletal muscle biology, bone metabolism, molecular pharmacology, reproductive endocrinology

Safety Precautions 

S-23 is supplied exclusively for laboratory research and should only be handled by qualified personnel using established laboratory safety procedures. Because S-23 remains an investigational androgen receptor modulator with limited human safety data, appropriate laboratory handling, storage, documentation, and disposal practices should be followed throughout all research activities.

• Research use only
• Not for human consumption
• Not intended to diagnose, treat, or prevent disease
• Wear appropriate personal protective equipment, including gloves, laboratory coat, and eye protection
• Follow aseptic handling procedures where appropriate
• Store under recommended laboratory storage conditions
• Avoid unnecessary freeze–thaw cycles where applicable
• Maintain accurate labeling and research documentation
• Dispose of waste in accordance with institutional and regulatory laboratory requirements
• Limited human safety data available
• Potential unknown long-term biological effects

Conclusion 

S-23 is a potent investigational selective androgen receptor modulator that has become an important research tool for studying androgen receptor pharmacology, skeletal muscle physiology, bone biology, and endocrine regulation. Its selective interaction with androgen receptors has made it valuable for exploring tissue-specific anabolic signaling mechanisms.

Studies into S-23 demonstrate biological activity involving muscle-related pathways, bone remodeling, and hormonal regulation. Continued investigation of S-23 may contribute to a broader understanding of selective androgen receptor modulation and the molecular pathways governing musculoskeletal and endocrine physiology.